Ambrisentan (Letairis) and Tadalafil (Adcirca) for Pulmonary Arterial Hypertension

被引：0
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2016年 / 58卷 / 1485期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2 / 4
页数：3
相关论文
共 50 条
  • [41] Oral Tadalafil in Children with Pulmonary Arterial Hypertension
    Shiva, A.
    Shiran, M.
    Rafati, M.
    Zamani, H.
    Babazadeh, K.
    Saeedi, M.
    Ala, S.
    DRUG RESEARCH, 2016, 66 (01) : 7 - 10
  • [42] Simultaneous LC-MS analysis of plasma concentrations of sildenafil, tadalafil, bosentan, ambrisentan, and macitentan in patients with pulmonary arterial hypertension
    Tanaka, S.
    Uchida, S.
    Hakamata, A.
    Miyakawa, S.
    Odagiri, K.
    Inui, N.
    Watanabe, H.
    Namiki, N.
    PHARMAZIE, 2020, 75 (06): : 236 - 239
  • [43] Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension: cLinical and haemodYnamic long-term efficacy (ITALY study)
    D'Alto, Michele
    Romeo, Emanuele
    Argiento, Paola
    Paciocco, Giuseppe
    Prediletto, Renato
    Ghio, Stefano
    Correale, Michele
    Lo Giudice, Francesco
    Badagliacca, Roberto
    Greco, Alessandra
    Vizza, Carmine Dario
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (01) : 12 - 17
  • [44] Ambrisentan therapy for pulmonary arterial hypertension: A comparison by path etiology
    Badesch, David B.
    CHEST, 2007, 132 (04) : 488S - 489S
  • [45] Combination Therapy With Ambrisentan And Tadalafil Effectively Treats Severe Pulmonary Hypertension In Female Rats
    Glickman, S.
    Akers, S.
    Staicu, S. A.
    Haight, D.
    White, R. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [46] Impact of transition from Sitaxsentan to Ambrisentan in Pulmonary Arterial Hypertension
    Safdar, Z.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [47] THE COST EFFECTIVENESS OF AMBRISENTAN FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN IRELAND
    Redmond, S.
    Bozkaya, D.
    VALUE IN HEALTH, 2009, 12 (07) : A329 - A329
  • [48] Pharmacokinetics of ambrisentan in a patient with Pulmonary Arterial Hypertension and a total gastrectomy
    Abston, Eric
    Farber, Harrison W.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2019, 57
  • [49] Sildenafil versus Ambrisentan in a Rat Model of Pulmonary Arterial Hypertension
    Senese, P. B.
    Martinez, T.
    Doherty, K. R.
    Bi, J.
    Wang, H.
    Zammit, M.
    Gralinski, M. R.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2020, 39 (01) : 76 - 76
  • [50] Sildenatil versus ambrisentan in a rat model of pulmonary arterial hypertension
    Senese, P. B.
    Martinez, T.
    Doherty, K. R.
    Bi, J.
    Wang, H.
    Zammit, M. D.
    Gralinski, M. R.
    Hock, F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (SUPPL 1) : 63 - 64
12345